Sanofi and PATH announce the Launch of Large-scale Production of Semisynthetic Artemisinin against Malaria

Paris, France, and South San Francisco, California – April 11, 2013 – Sanofi (EURONEXT: SAN and NYSE: SNY) and PATH’s Drug Development program, established through an affiliation with OneWorld Health, today announced the launch of the large-scale production line of semisynthetic artemisinin at Sanofi’s Garessio site in Italy.